Quantum BioPharma Ltd (NASDAQ:QNTM) has a beta value of -0.00 and has seen 14.08 million shares traded in the last trading session. The company, currently valued at $16.44M, closed the last trade at $8.56 per share which meant it gained $0.18 on the day or 2.15% during that session. The QNTM stock price is -447.55% off its 52-week high price of $46.87 and 68.46% above the 52-week low of $2.70. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.71 million shares traded. The 3-month trading volume is 2.60 million shares.

Quantum BioPharma Ltd (NASDAQ:QNTM) trade information

Sporting 2.15% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the QNTM stock price touched $8.56 or saw a rise of 31.24%. Year-to-date, Quantum BioPharma Ltd shares have moved 132.61%, while the 5-day performance has seen it change 51.24%. Over the past 30 days, the shares of Quantum BioPharma Ltd (NASDAQ:QNTM) have changed 73.28%. Short interest in the company has seen 47433.0 shares shorted with days to cover at 0.25.

Quantum BioPharma Ltd (QNTM) estimates and forecasts

The company’s shares have gained 125.26% over the past 6 months.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 48.95% over the past 5 years.

QNTM Dividends

Quantum BioPharma Ltd is expected to release its next earnings report on 2024-Nov-10 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Quantum BioPharma Ltd (NASDAQ:QNTM)’s Major holders

Insiders own 11.46% of the company shares, while shares held by institutions stand at 14.84% with a share float percentage of 16.76%. Investors are also buoyed by the number of investors in a company, with Quantum BioPharma Ltd having a total of 10.0 institutions that hold shares in the company.